Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.845 INR | +1,36% | +5,26% | -4,12% |
25/03 | Gland Pharma COO, Chief Technical Officer treden terug | MT |
27/02 | Gland Pharma benoemt nieuwe president van dochteronderneming Phixen | MT |
Vakgebied
Aantal werknemers: 4 585
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Generic Injectibles
100,0
%
| 44 007 | 100,0 % | 36 246 | 100,0 % | -17,64% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
57,7
%
| 23 327 | 53,0 % | 20 910 | 57,7 % | -10,36% |
Rest of World
19,0
%
| 8 481 | 19,3 % | 6 893 | 19,0 % | -18,73% |
India
15,3
%
| 8 801 | 20,0 % | 5 548 | 15,3 % | -36,96% |
Europe
5,2
%
| 2 398 | 5,4 % | 1 871 | 5,2 % | -21,97% |
Canada
2,2
%
| 829 | 1,9 % | 795 | 2,2 % | -4,14% |
Australia
0,6
%
| 171 | 0,4 % | 218 | 0,6 % | +27,72% |
New Zealand
0,0
%
| - | - | 11 | 0,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Srinivas Sadu
CEO | Chief Executive Officer | 54 | 01-01-00 |
Director of Finance/CFO | - | 30-09-19 | |
C. S. Venkatesan
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-98 |
Compliance Officer | - | 01-12-10 | |
Chief Tech/Sci/R&D Officer | - | 01-01-02 | |
Chief Operating Officer | - | 01-01-16 | |
K. V. G. K. Raju
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-92 |
Manish Bharadwaj
HRO | Human Resources Officer | - | - |
Rong Wu
AUD | Comptroller/Controller/Auditor | - | - |
Shilpi Sahay
PRN | Corporate Officer/Principal | - | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10-03-22 |
Srinivas Sadu
CEO | Chief Executive Officer | 54 | 01-01-00 |
Yiu Kwan Lau
CHM | Chairman | 69 | 10-06-19 |
Qi Yu Chen
BRD | Director/Board Member | 51 | 03-10-17 |
Director/Board Member | 69 | 07-02-18 | |
Naina Lal Kidwai
BRD | Director/Board Member | 66 | 17-05-21 |
Director/Board Member | 57 | 20-11-18 | |
Director/Board Member | - | 30-09-20 | |
Jia Ai Zhang
BRD | Director/Board Member | - | 17-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 164 710 523 | 61 190 971 ( 37,15 %) | 0 | 37,15 % |
Bedrijfsgegevens
Gland Pharma Ltd.
TSIIC Phase: IV Plot No. 11 & 84
502307, Sangareddy
+91 84 5569 9999
http://www.glandpharma.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Gland Pharma International Pte Ltd.
Gland Pharma International Pte Ltd. Pharmaceuticals: MajorHealth Technology Gland Pharma International Pte Ltd. is a Singaporean company that manufactures liquid parenteral products. The private company is based in Singapore, Singapore and was founded in 2021. |
Pharmaceuticals: Major
|
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,12% | 3,65 mld. | |
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+0,74% | 209 mld. | |
+2,95% | 212 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. |
- Beurs
- Aandelen
- Aandeel Gland Pharma Limited - NSE India S.E.
- Onderneming Gland Pharma Limited